Literature DB >> 30924388

Signal intensity increases in dentate nucleus/globus pallidus/pulvinar on unenhanced T1WI MR images after multiple examinations with gadodiamide.

Takao Koiso1,2, Masaaki Yamamoto1,3, Shinya Watanabe2, Bierta E Barfod1.   

Abstract

BACKGROUND AND
PURPOSE: Elevated signal intensity (SI) in the dentate nucleus (DN), globus pallidus (GP) and pulvinar (PUL) was reportedly observed on unenhanced T1-weighted (T1WI) magnetic resonance (MR) images in patients receiving multiple enhanced MR examinations. We aimed to clarify whether this phenomenon influences the long-term neurological status of patients.
MATERIALS AND METHODS: We studied 196 radiosurgically treated patients undergoing ≥10 MR examinations using a single dose of gadodiamide and the same 1.5 Tesla MR unit. SI ratios were calculated by referencing the brainstem (BS) for the DN and the thalamus (TH) for the GP and PUL. We compared the SI ratios at the first, fifth, and 10th, and at the most recent examinations. The neurological symptoms of all 196 patients were assessed at each MR examination by one of the authors (MY).
RESULTS: The DN/BS and GP/TH SI ratios were significantly increased at the fifth examination ( p < .0001, p = 0.0094) and, thereafter, gradually increased. Although the PUL/TH SI ratio was not significantly increased at the fifth examination ( p = 0.2515), a significant increase was noted at the 10th examination ( p < .0001). There were no significant predictive factors for DN/BS SI increases. Younger age, no brain metastasis, and normal estimated glomerular filtration rate were related to GP/TH SI ratio increases ( p = 0.0308, p = 0.0001, p = 0.0306). Higher age and total bilirubin level were related to an increased PUL/TH SI ratio ( p = 0.0276, p = 0.0097). No patients experienced gadodiamide-related health problems.
CONCLUSIONS: Although the SI ratios rose as numbers of gadodiamide administrations increased, no adverse health effects have developed to date.

Entities:  

Keywords:  Dentate nucleus; gadolinium; globus pallidus; magnetic resonance imaging; pulvinar; signal intensity; signal intensity changes

Mesh:

Substances:

Year:  2019        PMID: 30924388      PMCID: PMC6512212          DOI: 10.1177/1971400919839646

Source DB:  PubMed          Journal:  Neuroradiol J        ISSN: 1971-4009


  35 in total

1.  Effects of gadopentetate dimeglumine administration after osmotic blood-brain barrier disruption: toxicity and MR imaging findings.

Authors:  S M Roman-Goldstein; P A Barnett; C I McCormick; M J Ball; F Ramsey; E A Neuwelt
Journal:  AJNR Am J Neuroradiol       Date:  1991 Sep-Oct       Impact factor: 3.825

2.  Anomalous intracranial venous drainage associated with basal ganglia calcification.

Authors:  Z Chen; H Feng; G Zhu; N Wu; J Lin
Journal:  AJNR Am J Neuroradiol       Date:  2007-01       Impact factor: 3.825

3.  Gadolinium encephalopathy in a patient with renal failure.

Authors:  Boby Varkey Maramattom; Edward M Manno; Eelco F M Wijdicks; Edward P Lindell
Journal:  Neurology       Date:  2005-04-12       Impact factor: 9.910

4.  Toxicological assessment of gadolinium release from contrast media.

Authors:  Simona Bussi; Xavier Fouillet; Alberto Morisetti
Journal:  Exp Toxicol Pathol       Date:  2006-12-05

5.  Incorporation of excess gadolinium into human bone from medical contrast agents.

Authors:  Thomas H Darrah; Jennifer J Prutsman-Pfeiffer; Robert J Poreda; M Ellen Campbell; Peter V Hauschka; Robyn E Hannigan
Journal:  Metallomics       Date:  2009-09-16       Impact factor: 4.526

6.  Long-term retention of gadolinium in tissues from nephrogenic systemic fibrosis patient after multiple gadolinium-enhanced MRI scans: case report and implications.

Authors:  Charu Thakral; Jihad Alhariri; Jerrold L Abraham
Journal:  Contrast Media Mol Imaging       Date:  2007-07       Impact factor: 3.161

Review 7.  Biodistribution of gadolinium-based contrast agents, including gadolinium deposition.

Authors:  Silvio Aime; Peter Caravan
Journal:  J Magn Reson Imaging       Date:  2009-12       Impact factor: 4.813

8.  Comparison of Gd(DTPA-BMA) (Omniscan) versus Gd(HP-DO3A) (ProHance) relative to gadolinium retention in human bone tissue by inductively coupled plasma mass spectroscopy.

Authors:  Gregory W White; Wendell A Gibby; Michael F Tweedle
Journal:  Invest Radiol       Date:  2006-03       Impact factor: 6.016

Review 9.  Tissue distribution and kinetics of gadolinium and nephrogenic systemic fibrosis.

Authors:  Jerrold L Abraham; Charu Thakral
Journal:  Eur J Radiol       Date:  2008-05       Impact factor: 3.528

Review 10.  Nephrogenic systemic fibrosis: histology and gadolinium detection.

Authors:  Charu Thakral; Jerrold L Abraham
Journal:  Radiol Clin North Am       Date:  2009-09       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.